+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Head & Neck Cancer Diagnostics Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon

    Report

  • 218 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5753537
The Global The Head & Neck Cancer Diagnostics Market is estimated to be USD 1.77 Bn in 2023 and is expected to reach USD 3.87 Bn by 2028 growing at a CAGR of 16.92%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Head & Neck Cancer Diagnostics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Head & Neck Cancer Diagnostics Market is segmented based on Diagnostic Method, End User, and Geography.
  • By Diagnostic Method, the market is classified into Bioscopy Screening Tests, Dental Diagnostic Methods, Diagnostic Imaging Equipment, and Endoscopy Screening Equipment.
  • By End User, the market is classified into Diagnostic Centers and Hospitals.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Addent, Inc., Carestream Healthcar, Canon Medical system Corp., Varian Medical Systems, etc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Head & Neck Cancer Diagnostics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Head & Neck Cancer Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Head & Neck Cancer Diagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Number of Diagnostic Procedures for Head & Neck Cancer
4.1.2 Rise In Government & Private Body Initiatives for Cancer Diagnostic
4.1.3 Rising Human Healthcare Expenditure and Increasing Demand for Diagnostic Imaging
4.2 Restraints
4.2.1 High Cost of Devices & Unfavourable Reimbursement Scenarios
4.3 Opportunities
4.3.1 New Advancements & Innovations in Diagnostic Methodology
4.3.2 Large Research Funding in Oncological Advancement
4.4 Challenges
4.4.1 Dearth of Trained Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of Covid-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Head & Neck Cancer Diagnostics Market, By Diagnostic Method
6.1 Introduction
6.2 Bioscopy Screening Tests
6.3 Dental Diagnostic Methods
6.4 Diagnostic Imaging Equipment
6.5 Endoscopy Screening Equipment
7 Global Head & Neck Cancer Diagnostics Market, By End User
7.1 Introduction
7.2 Diagnostic Centers
7.3 Hospitals
8 America's Head & Neck Cancer Diagnostics Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Head & Neck Cancer Diagnostics Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Head & Neck Cancer Diagnostics Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Head & Neck Cancer Diagnostics Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Addent, Inc.
13.2 Carestream Healthcare
13.3 Canon Medical System Corp.
13.4 Fujifilm Holdings
13.5 GE Healthcare
13.6 Hitachi Medical
13.7 Identafi
13.8 Neusoft Medical
13.9 Philips Healthcare
13.10 Planet DDS
13.11 Siemens Healthcare
13.12 Toshiba
13.13 Varian Medical Systems
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Addent, Inc.
  • Carestream Healthcare
  • Canon Medical System Corp.
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical
  • Identafi
  • Neusoft Medical
  • Philips Healthcare
  • Planet DDS
  • Siemens Healthcare
  • Toshiba
  • Varian Medical Systems